These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 926845)
21. Growth inhibition of tubercle bacilli after pulsed exposures to combinations of antituberculous drugs. Beggs WH Res Commun Chem Pathol Pharmacol; 1975 Jul; 11(3):487-90. PubMed ID: 807961 [TBL] [Abstract][Full Text] [Related]
22. [Observations of properties of the L-form of M. tuberculosis induced by the antituberculosis drugs]. Wang H; Chen Z Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):52-5. PubMed ID: 11802941 [TBL] [Abstract][Full Text] [Related]
24. Rapid oral desensitization to isoniazid, rifampin, and ethambutol. Kim JH; Kim HB; Kim BS; Hong SJ Allergy; 2003 Jun; 58(6):540-1. PubMed ID: 12757467 [No Abstract] [Full Text] [Related]
26. [Resistance of mycobacterial tuberculosis complex to the main antibacillary agent in Yaounde, Cameroon]. Bercion R; Kuaban C Bull Soc Pathol Exot; 1998; 91(3):199-202. PubMed ID: 9773189 [TBL] [Abstract][Full Text] [Related]
27. [Epidemiology of the resistance of Mycobacterium tuberculosis to antituberculosis drugs at the main hospital in Dakar, Senegal. A 4-year retrospective study (2000-2003)]. Chevalier B; Margery J; Sane M; Camara P; Lefebvre N; Gueye M; Thiam M; Perrier-Gros-Claude JD; Simon F; Fabre M; Soler C; Herve V; Mbaye PS; Debonne JM Rev Pneumol Clin; 2010 Sep; 66(4):266-71. PubMed ID: 20933169 [TBL] [Abstract][Full Text] [Related]
29. [Remission of pulmonary alveolar proteinosis during antituberculosis chemotherapy]. Onari Y; Yamaoka N; Taniwaki M; Nakao R; Murai H; Terada M; Kuraoka T Nihon Kokyuki Gakkai Zasshi; 2003 Jun; 41(6):392-6. PubMed ID: 12833844 [TBL] [Abstract][Full Text] [Related]
30. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
31. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987. Jalleh RD; Kuppusamy I; Soshila R; Aziah AM; Faridza MY Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784 [TBL] [Abstract][Full Text] [Related]
32. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis. Konno K; Oizumi K; Yamada S; Ogata K; Sato M Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624 [No Abstract] [Full Text] [Related]
33. [Antituberculosis chemotherapy including ofloxacin in patients with pulmonary tuberculosis not treated previously]. Tsukamura M; Yoshii S; Yasuda Y; Saito H Kekkaku; 1986 Jan; 61(1):15-7. PubMed ID: 3458966 [No Abstract] [Full Text] [Related]
34. [Drugs used in tuberculosis and leprosy]. Aoyagi T; Toyoda T Nihon Rinsho; 1990 Oct; 48(10):2212-7. PubMed ID: 2280466 [No Abstract] [Full Text] [Related]
35. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis. Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119 [TBL] [Abstract][Full Text] [Related]
36. [The resistance rates of Mycobacterium tuberculosis strains to antituberculosis drugs: evaluation of two years' data in Aegean region, Turkey]. Güneri S; Unsal I; Oztop A; Erkut M; Avkan Oğuz V; Ozgü A; Cakmak R Mikrobiyol Bul; 2004 Jul; 38(3):203-12. PubMed ID: 15490839 [TBL] [Abstract][Full Text] [Related]
38. [Sensitivity to rifampicin and ethambutol of mycobacteria resistant to isoniazid or streptomycin]. Golychevskaja VI G Ital Chemioter; 1972; 19(2):20-2. PubMed ID: 4199029 [No Abstract] [Full Text] [Related]